GSK to pay $2.1 billion upfront and up to $1.2 billion in …
Next-gen vaccines set to maintain immunity as the years advance
Vaccine potency drops in the elderly and little is known about why …
Antibiotics impact gut microbiome and antimicrobial resistance
Antibiotics are commonly used to treat infections and ensure the safety of …
MEMBER NEWS: IPA Completes Acquisition of Belgian Technology Companies BioStrand, BioKey, and BioClue
VICTORIA, BRITISH COLUMBIA (CANADA), April 14, 2022 – IPA (IMMUNOPRECISE ANTIBODIES LTD.) …
MEMBER NEWS: eTheRNA Announces Relocation and Expansion of R&D Facility
GENT, BELGIUM, April 5, 2022 – eTheRNA immunotherapies NV (“eTheRNA”), an mRNA …
Vaccinopolis: University of Antwerp opens unique centre for vaccine studies
A new centre dedicated to vaccine studies and infectious disease research opened …
Beschermt het kindervaccin tegen ziekte? En hoe veilig is het?
Nu de vaccinatiecampagne voor 5- tot 11-jarigen volop loopt, zitten heel wat …
MEMBER NEWS: BioStrand secures second VLAIO research grant
Half-million Euro grant to power BioStrand platform expansion to structure analysis and improved AI …
TRANSVAC: 15 January 2022 deadline open call for application (13th cut-off)
TRANSVAC is a new infrastructure project – funded by the European Commission …
Omikronvariant van het coronavirus maakt wereld nerveus: dit weten we erover
Precies op de dag dat het Overlegcomité strengere maatregelen introduceerde, is een …